All In MedTech

Device Trial Radar · NCT06902766

Towards Digital Management of Paediatric Asthma

Towards Digital Management of Pediatric Asthma:a Pilot Study

Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Nov 25, 2025

Primary completion

Jul 2027

Study completion Jul 2027

Sponsor

Lead sponsor
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
URC-CIC Paris Descartes Necker Cochin
First posted
Mar 30, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
All sexes, from 4 years, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot study aims to explore whether a digital approach to managing childhood asthma using connected inhalers and video consultations triggered by alerts from these devices - could work as well as standard in-person care. The connected inhalers track when children use their daily prevention medication and their rescue medication for asthma symptoms. If a child misses several days of prevention medication or uses their rescue inhaler frequently, their doctor receives an alert and can schedule a video consultation to adjust their treatment. Fifty children aged 4-12 years with asthma will participate for 8 months, with half using this digital system and half receiving usual care. The study will measure whether this new approach is practical and acceptable to families and doctors, and will look at its effects on asthma control, quality of life, and healthcare use. The results will help design a larger study to fully test if this digital approach could improve asthma care for children.

Conditions

  • Pediatric Asthma

Interventions

  • Active telemonitoring using real-time data from digital inhalers.Device

    Telemonitoring system relying on the use of 2 digital inhalers FindAir ONE for pMDI,one for the controller the other for the reliever treatment. Active telemonitoring using real-time data from digital inhalers Investigators will be alerted by email if a child: * fails to take his or her controller treatment for 4 continuous days and/or * uses \> 4 doses of reliever treatment over 24 hours * uses \< 12 doses of reliever treatment over 3 months (indication to decrease the controller treatment). For alert (2), a teleconsultation will be scheduled within 2 working days to assess and adapt treatment as needed. Emergency treatment may be adjusted for approximately one week. Alerts within the following 7 days will be considered part of the same clinical episode. For alerts (1) and (3), a teleconsultation will be scheduled within 7 working days to assess and adapt management as needed.Spirometry and pulse oximetry if needed.

  • StandardOther

    Standardized care + passive recording of asthma treatment use (controller and reliever treatments) using digital inhalers

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in asthma severity measured by the Composite Asthma Severity Index (CASI)Time frame: At the inclusion visit (baseline) and 8 months (+/- 1 month) (end of study) in each group

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hôpital Necker Enfants Malades AP-HP

    Paris, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.